FDA approves Cerus’ INTERCEPT blood system for cryoprecipitation
The INTERCEPT blood system will facilitate the production of pathogen reduced cryoprecipitated fibrinogen. (Credit: PublicDomainPictures from Pixabay)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X